NHS England updates CDF List

NHS England has upded the Cancer Drugs Fund List on its website. We have updated our website to correspond.

NHS England updates CDF List

NHS England has updated the Cancer Drugs Fund List. The latest version (v1.359) was uploaded to the NHS England Website on Friday 11, April 2025.

The following changes have been introduced:

Capivasertib in combination with fulvestrant (CAP1)

Capivasertib in combination with fulvestrant for hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer in patients previously treated with a CDK4/6 inhibitor and an aromatase inhibitor where the following criteria have been met

Recommended for routine commissioning, receiving CDF interim funding